Literature DB >> 23948164

Intracellular signaling mechanisms associated with CD47 modified surfaces.

Matthew J Finley1, Katherine A Clark, Ivan S Alferiev, Robert J Levy, Stanley J Stachelek.   

Abstract

We have previously established that recombinant CD47 can ameliorate the inflammatory response to synthetic polymeric surfaces. Here, we begin to profile, at the transcriptional, translational and cell signaling level, the inflammatory cell response when blood interacts with CD47 modified polyvinyl chloride (PVC) (CD47-PVC). We used qPCR arrays to compare transcriptional changes between human whole blood exposed to CD47-PVC or PVC. Transcription of IL1F5, IL1F10, IL17F, CCL3, CCL8, CCL28, CXCL12, and CXCL13 was upregulated in blood exposed to PVC, compared to CD47-PVC. The increase in CCL3 and CCL8 transcription correlated with an increase in the chemokines' presence in the plasma. Exposure of blood to CD47-PVC resulted in an increase, compared to PVC, in transcription of CCL2, CCL4, CCL20, CXCL1, TGFβ3, GDF3, GDF10, CD40LG, and TNFSF10. CD47-PVC exposure resulted in an increase of the following matrix metalloproteinase related genes: MMP1, MMP7, MMP13, and MMP16. Phosflow cytometry, and assays examining transcription factor binding, cell attachment, and genome-wide chromatin association indicated that members of the JAK-STAT signaling pathway, particularly JAK2 and STAT5, mediate inflammatory cell interactions with CD47-PVC. Our data demonstrate that differential molecular responses to CD47 involve downregulation of cytokines, upregulation of MMPs, and JAK/STAT signaling mechanisms.
© 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biocompatibility; Cell signaling; Gene expression; Metalloproteinase

Mesh:

Substances:

Year:  2013        PMID: 23948164      PMCID: PMC3804223          DOI: 10.1016/j.biomaterials.2013.07.088

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  46 in total

Review 1.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

Review 2.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

Authors:  D Paparella; T M Yau; E Young
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

3.  Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.

Authors:  Richard K Tsai; Pia L Rodriguez; Dennis E Discher
Journal:  Blood Cells Mol Dis       Date:  2010-03-17       Impact factor: 3.039

4.  Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating.

Authors:  Joerg Seeburger; Jan Hoffmann; Hans Peter Wendel; Gerhard Ziemer; Hermann Aebert
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

Review 5.  New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway.

Authors:  John J O'Shea; Heiyoung Park; Marko Pesu; Dominic Borie; Paul Changelian
Journal:  Curr Opin Rheumatol       Date:  2005-05       Impact factor: 5.006

Review 6.  Improved biomaterials for tissue engineering applications: surface modification of polymers.

Authors:  Rajesh Vasita; Kirubanandan Shanmugam I; Dhirendra S Katt
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  In vitro hemocompatibility of self-assembled monolayers displaying various functional groups.

Authors:  Claudia Sperling; Rüdiger B Schweiss; Uwe Streller; Carsten Werner
Journal:  Biomaterials       Date:  2005-11       Impact factor: 12.479

Review 9.  Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.

Authors:  Lothar Hennighausen; Gertraud W Robinson
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

Review 10.  The role of MIP-1 alpha in inflammation and hematopoiesis.

Authors:  D N Cook
Journal:  J Leukoc Biol       Date:  1996-01       Impact factor: 4.962

View more
  7 in total

1.  Enhanced biocompatibility of CD47-functionalized vascular stents.

Authors:  Joshua B Slee; Ivan S Alferiev; Chandrasekaran Nagaswami; John W Weisel; Robert J Levy; Ilia Fishbein; Stanley J Stachelek
Journal:  Biomaterials       Date:  2016-02-08       Impact factor: 12.479

Review 2.  Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.

Authors:  Bryan N Brown; Martin J Haschak; Samuel T Lopresti; Elizabeth C Stahl
Journal:  Semin Immunol       Date:  2017-05-20       Impact factor: 11.130

3.  The use of the ex vivo Chandler Loop Apparatus to assess the biocompatibility of modified polymeric blood conduits.

Authors:  Joshua B Slee; Ivan S Alferiev; Robert J Levy; Stanley J Stachelek
Journal:  J Vis Exp       Date:  2014-08-20       Impact factor: 1.355

Review 4.  The use of CD47-modified biomaterials to mitigate the immune response.

Authors:  Jillian E Tengood; Robert J Levy; Stanley J Stachelek
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

5.  Effects of aging upon the host response to implants.

Authors:  Daniel Hachim; Na Wang; Samuel T Lopresti; Elizabeth C Stahl; Yuta U Umeda; Rahul D Rege; Sean T Carey; Deepa Mani; Bryan N Brown
Journal:  J Biomed Mater Res A       Date:  2017-02-14       Impact factor: 4.396

6.  Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization.

Authors:  Stanley J Stachelek; Ilia Fishbein; Vaishali V Inamdar; Emmett G Fitzpatrick; Ivan S Alferiev; Robert J Levy
Journal:  J Vis Exp       Date:  2020-12-03       Impact factor: 1.355

7.  Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors.

Authors:  Joshua B Slee; Abigail J Christian; Robert J Levy; Stanley J Stachelek
Journal:  Polymers (Basel)       Date:  2014-09-29       Impact factor: 4.329

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.